Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice.
Yun Rose LiKyle D HalliwillCassandra J AdamsVivek IyerLaura RivaRashid MamunurKuang-Yu JenReyno Del RosarioErik FredlundGillian L HirstLudmil B AlexandrovDavid J AdamsAllan BalmainPublished in: Nature communications (2020)
Ionising radiation (IR) is a recognised carcinogen responsible for cancer development in patients previously treated using radiotherapy, and in individuals exposed as a result of accidents at nuclear energy plants. However, the mutational signatures induced by distinct types and doses of radiation are unknown. Here, we analyse the genetic architecture of mammary tumours, lymphomas and sarcomas induced by high (56Fe-ions) or low (gamma) energy radiation in mice carrying Trp53 loss of function alleles. In mammary tumours, high-energy radiation is associated with induction of focal structural variants, leading to genomic instability and Met amplification. Gamma-radiation is linked to large-scale structural variants and a point mutation signature associated with oxidative stress. The genomic architecture of carcinomas, sarcomas and lymphomas arising in the same animals are significantly different. Our study illustrates the complex interactions between radiation quality, germline Trp53 deficiency and tissue/cell of origin in shaping the genomic landscape of IR-induced tumours.
Keyphrases
- copy number
- radiation induced
- oxidative stress
- genome wide
- single cell
- early stage
- newly diagnosed
- radiation therapy
- squamous cell carcinoma
- adipose tissue
- gene expression
- diabetic rats
- dna methylation
- quality improvement
- endoplasmic reticulum stress
- rectal cancer
- mesenchymal stem cells
- dna repair
- tyrosine kinase
- patient reported outcomes
- water soluble